Nelson, Van Denburg & Campbell Wealth Management Group, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.75 Billion
- Q2 2025
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 5,635 shares of RYTM stock, worth $557,977. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,635
Previous 4,589
22.79%
Holding current value
$557,977
Previous $243,000
46.5%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RYTM
# of Institutions
246Shares Held
64MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$668 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$555 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$551 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$483 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$355 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.52B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...